EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register

Mattias Tallroth iD, Ruzan Udumyan iD, András Büki iD, Mia von Euler iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.034716 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Mattias Tallroth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Rehabilitation, Faculty of Medicine and Health Örebro University Örebro Sweden. Hauptthemen laut MEDLINE: Registries, Cerebral Hemorrhage, Fibrinolytic Agents, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background A rapid shift has occurred from vitamin K antagonists toward direct oral anticoagulants, which have a lower risk of intracerebral hemorrhage (ICH). However, effects on clinical outcomes after ICH are understudied. We aimed to describe the prevalence of antithrombotic drugs and to study the prognosis among prestroke functionally independent Swedish patients with ICH. Methods and Results We identified all patients diagnosed with nontraumatic ICH in 2017 to 2021 from the Swedish Stroke Register (n=13 155) and assessed death and functional outcome at 3 months after ICH in prestroke functionally independent patients (n=10 014). Functional outcome was estimated among 3‐month survivors on the basis of self‐reported activities of daily living scores. Risks of outcomes were estimated using Poisson regression. In 13 155 patients, 14.5% used direct oral anticoagulant, 10.1% vitamin K antagonists, and 21.6% antiplatelets at ICH onset. Among 10 014 pre‐stroke activities of daily living–independent patients, oral anticoagulants and antiplatelets were associated with increased mortality risk (adjusted risk ratio, 1.27 [95% CI, 1.13–1.43]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesCerebral HemorrhageFibrinolytic AgentsAnticoagulantsHumansMaleFemaleSwedenAgedRetrospective StudiesAged, 80 and overMiddle AgedPlatelet Aggregation InhibitorsTreatment OutcomeStrokeVitamin KAdministration, OralActivities of Daily LivingRisk FactorsRisk Assessment

Stichwörter der Autor:innen

antithrombotic drugsdeathfunctional outcomeintracerebral hemorrhageoral anticoagulants

Substanzen

Fibrinolytic AgentsAnticoagulantsPlatelet Aggregation InhibitorsVitamin K

Autor:innen und Institutionen

  • Department of Neurology and Rehabilitation, Faculty of Medicine and Health Örebro University Örebro Sweden.
  • Department of Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health Örebro University Örebro Sweden.
  • Department of Neurosurgery, Faculty of Medicine and Health Örebro University Örebro Sweden.

ORCID-Profile: Mattias Tallroth, Ruzan Udumyan, András Büki, Mia von Euler

Zitieren

APA

Tallroth, M., Udumyan, R., Büki, A., & von Euler, M. (2024). Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.034716

Vancouver

Tallroth M, Udumyan R, Büki A, von Euler M. Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.034716

BibTeX
@article{Tallroth2024,
  author = {Tallroth, Mattias and Udumyan, Ruzan and Büki, András and von Euler, Mia},
  title = {Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.034716}
}
Kostenlos starten →